JP2009502112A - 腎細胞癌を診断および処置するための方法 - Google Patents

腎細胞癌を診断および処置するための方法 Download PDF

Info

Publication number
JP2009502112A
JP2009502112A JP2008503300A JP2008503300A JP2009502112A JP 2009502112 A JP2009502112 A JP 2009502112A JP 2008503300 A JP2008503300 A JP 2008503300A JP 2008503300 A JP2008503300 A JP 2008503300A JP 2009502112 A JP2009502112 A JP 2009502112A
Authority
JP
Japan
Prior art keywords
rcc
expression
gene
cells
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008503300A
Other languages
English (en)
Japanese (ja)
Inventor
祐輔 中村
豊雅 片桐
修一 中鶴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of JP2009502112A publication Critical patent/JP2009502112A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2008503300A 2005-07-28 2006-07-21 腎細胞癌を診断および処置するための方法 Pending JP2009502112A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70364005P 2005-07-28 2005-07-28
US79996006P 2006-05-11 2006-05-11
PCT/JP2006/314946 WO2007013575A2 (fr) 2005-07-28 2006-07-21 Procede pour le diagnostic et le traitement d'hypernephrome

Publications (1)

Publication Number Publication Date
JP2009502112A true JP2009502112A (ja) 2009-01-29

Family

ID=37401179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008503300A Pending JP2009502112A (ja) 2005-07-28 2006-07-21 腎細胞癌を診断および処置するための方法

Country Status (3)

Country Link
EP (1) EP1907580A2 (fr)
JP (1) JP2009502112A (fr)
WO (1) WO2007013575A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012023284A1 (fr) * 2010-08-20 2012-02-23 Oncotherapy Science, Inc. Lhx4 comme gène cible pour le traitement et le diagnostic du cancer
WO2012141201A1 (fr) * 2011-04-11 2012-10-18 公立大学法人大阪市立大学 Peptide pour l'immunothérapie du cancer et procédé d'utilisation de celui-ci
JP2016086678A (ja) * 2014-10-30 2016-05-23 公立大学法人福島県立医科大学 腎がんの悪性度の検査マーカー及び検査方法
JP2017141517A (ja) * 2016-02-09 2017-08-17 株式会社三泉 加温システム
JP2022518702A (ja) * 2019-01-16 2022-03-16 オスペダーレ・サン・ラッファエーレ・エッセエッレエッレ 腎細胞癌のバイオマーカー

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018642A2 (fr) 2006-08-10 2008-02-14 Oncotherapy Science, Inc. Gènes et polypeptides associés à des cancers du sein
US20100222230A1 (en) * 2007-04-11 2010-09-02 The General Hospital Corporation Diagnostic and prognostic methods for renal cell carcinoma
WO2009025116A1 (fr) 2007-08-20 2009-02-26 Oncotherapy Science, Inc. Peptide cdh3 et agent médicinal le comprenant
TWI543767B (zh) 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
EP2165710A1 (fr) 2008-09-19 2010-03-24 Institut Curie Récepteur TYRO3 de la tyrosine kinase en tant que cible thérapeutique dans le traitement d'une tumeur de la vessie
WO2010058572A1 (fr) 2008-11-20 2010-05-27 Oncotherapy Science, Inc. Procédés pour le diagnostic ou le traitement d'un cancer de la prostate
US8841067B2 (en) 2009-01-09 2014-09-23 Dana-Farber Cancer Institute, Inc. NOL3 is a predictor of patient outcome
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
WO2011153469A1 (fr) 2010-06-03 2011-12-08 Idexx Laboratories, Inc. Marqueurs de néphropathies
TW201302800A (zh) * 2011-06-10 2013-01-16 Oncotherapy Science Inc Ｓｅｍａ５ｂ胜肽及含其之疫苗
RU2015126849A (ru) * 2012-12-04 2017-01-12 Онкотерапи Сайенс, Инк. Пептиды sema5в и вакцины, содержащие эти пептиды
SG10201900835XA (en) 2014-08-04 2019-03-28 Oncotherapy Science Inc Urlc10-derived peptide and vaccine containing same
CN105567731B (zh) * 2016-02-24 2019-02-26 北京农学院 一种通过下调PAB4和PAB8提高植物对NaCl耐受性的方法
BR112018067292A2 (pt) 2016-03-02 2019-01-02 Idexx Lab Inc métodos e composições para a detecção e o diagnóstico de doença renal e doença periodontal
CN115948404A (zh) * 2023-02-01 2023-04-11 重庆医科大学 一种抑制环状RNA circPDHK1的siRNA及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
US20030109434A1 (en) * 2001-03-19 2003-06-12 Corixa Corporation Compositions and methods for the therapy and diagnosis of kidney cancer
WO2003101400A2 (fr) * 2002-06-04 2003-12-11 Avalon Pharmaceuticals, Inc. Gene lie au cancer comme cible de chimiotherapie
WO2004000997A2 (fr) * 2002-03-19 2003-12-31 Curagen Corporation Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
WO2004074506A2 (fr) * 2003-02-13 2004-09-02 Mergen Ltd Sequences polynucleotidiques et polypeptides codes correspondants de proteines specifiques secretees et liees a la membrane sur-exprimees dans certains cancers
WO2005019475A2 (fr) * 2003-08-20 2005-03-03 Oncotherapy Science, Inc. Proteine 2 inductible par l'hypoxie (hig2), nouvelle cible therapeutique potentielle de l'hypernephrome (rcc)
WO2005024603A2 (fr) * 2003-09-10 2005-03-17 The Board Of Regents Of The University Of Texas System Methodes pour detecter, pour diagnostiquer et pour traiter un carcinome cellulaire renal humain
DE10344799A1 (de) * 2003-09-26 2005-04-14 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012023284A1 (fr) * 2010-08-20 2012-02-23 Oncotherapy Science, Inc. Lhx4 comme gène cible pour le traitement et le diagnostic du cancer
WO2012141201A1 (fr) * 2011-04-11 2012-10-18 公立大学法人大阪市立大学 Peptide pour l'immunothérapie du cancer et procédé d'utilisation de celui-ci
JP2016086678A (ja) * 2014-10-30 2016-05-23 公立大学法人福島県立医科大学 腎がんの悪性度の検査マーカー及び検査方法
JP2017141517A (ja) * 2016-02-09 2017-08-17 株式会社三泉 加温システム
JP2022518702A (ja) * 2019-01-16 2022-03-16 オスペダーレ・サン・ラッファエーレ・エッセエッレエッレ 腎細胞癌のバイオマーカー

Also Published As

Publication number Publication date
WO2007013575A3 (fr) 2007-10-25
WO2007013575A2 (fr) 2007-02-01
EP1907580A2 (fr) 2008-04-09

Similar Documents

Publication Publication Date Title
JP2009502112A (ja) 腎細胞癌を診断および処置するための方法
JP4938451B2 (ja) 非小細胞肺癌の診断のための方法
JP4620670B2 (ja) 乳癌を診断する方法
US20070054849A1 (en) Method for diagnosing hepatocellular carcinomas
JP2009502115A (ja) 小細胞肺癌の診断方法
US20100204060A1 (en) Hypoxia-inducible protein 2 (hig 2), a diagnostic marker for clear cell renal cell carcinoma
JP2006500946A (ja) 精巣精上皮腫の診断方法
US20070253954A1 (en) Epha4 As Therapeutic Target Of Prc And Pdaca
JP2012125248A (ja) 結腸癌関連遺伝子ｔｏｍ３４
JP2009505632A (ja) 膵臓癌関連遺伝子であるｃｓｔ６およびｇａｂｒｐ
EP1907859B1 (fr) Genes et polypeptides associes aux cancers de la prostate
US8182997B2 (en) Prostate cancer related gene STYK1
JP2009505631A (ja) 癌関連遺伝子ｒａｓｇｅｆ１ａ
JP2008505601A (ja) 前立腺癌に関連した遺伝子及びポリペプチド